JP2007509960A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007509960A5 JP2007509960A5 JP2006538253A JP2006538253A JP2007509960A5 JP 2007509960 A5 JP2007509960 A5 JP 2007509960A5 JP 2006538253 A JP2006538253 A JP 2006538253A JP 2006538253 A JP2006538253 A JP 2006538253A JP 2007509960 A5 JP2007509960 A5 JP 2007509960A5
- Authority
- JP
- Japan
- Prior art keywords
- disorders
- pharmaceutical composition
- composition according
- nzojiazepin
- depressive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 206010001488 Aggression Diseases 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 206010010904 Convulsion Diseases 0.000 claims 1
- 208000020401 Depressive disease Diseases 0.000 claims 1
- 208000030814 Eating disease Diseases 0.000 claims 1
- 208000019454 Feeding and Eating disease Diseases 0.000 claims 1
- 208000007101 Muscle Cramp Diseases 0.000 claims 1
- 206010049816 Muscle tightness Diseases 0.000 claims 1
- 208000028017 Psychotic disease Diseases 0.000 claims 1
- 208000005392 Spasm Diseases 0.000 claims 1
- 206010047700 Vomiting Diseases 0.000 claims 1
- 230000016571 aggressive behavior Effects 0.000 claims 1
- 208000012761 aggressive behavior Diseases 0.000 claims 1
- 208000010877 cognitive disease Diseases 0.000 claims 1
- 230000003001 depressive effect Effects 0.000 claims 1
- 235000014632 disordered eating Nutrition 0.000 claims 1
- 208000030533 eye disease Diseases 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 230000000626 neurodegenerative effect Effects 0.000 claims 1
- 230000036407 pain Effects 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 230000008673 vomiting Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51504303P | 2003-10-28 | 2003-10-28 | |
| PCT/US2004/035822 WO2005044818A2 (en) | 2003-10-28 | 2004-10-28 | Imidazo[1,2-a]pyridine anxiolytics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007509960A JP2007509960A (ja) | 2007-04-19 |
| JP2007509960A5 true JP2007509960A5 (cg-RX-API-DMAC7.html) | 2007-11-29 |
Family
ID=34572796
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538253A Withdrawn JP2007509960A (ja) | 2003-10-28 | 2004-10-28 | イミダゾ［１，２−ａ］ピリジン抗不安薬 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7723324B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1682549B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007509960A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE482211T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004287847A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2544213A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE602004029272D1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005044818A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006327217A1 (en) * | 2005-11-28 | 2007-06-28 | Mallinckrodt Inc. | Improved method of preparation for Imidazolepyridines |
| EP1803722A1 (en) * | 2006-01-03 | 2007-07-04 | Ferrer Internacional, S.A. | Imidazo[1,2-a]pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof |
| AU2009249186B2 (en) * | 2008-05-19 | 2014-05-22 | Sunovion Pharmaceuticals Inc. | Imidazo [1, 2-a] pyridine compounds as GABA-A receptor modulators |
| WO2011041713A2 (en) * | 2009-10-02 | 2011-04-07 | Glaxosmithkline Llc | Piperazinyl antiviral agents |
| KR101774035B1 (ko) | 2009-10-30 | 2017-09-01 | 얀센 파마슈티카 엔.브이. | 이미다조［１，２―ｂ］피리다진 유도체 및 ＰＤＥ１０ 저해제로서의 그의 용도 |
| AR080754A1 (es) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
| PT2707101T (pt) * | 2011-05-12 | 2019-05-30 | Proteostasis Therapeutics Inc | Reguladores da proteostase |
| EA027418B1 (ru) | 2011-06-27 | 2017-07-31 | Янссен Фармацевтика Нв | ПРОИЗВОДНЫЕ 1-АРИЛ-4-МЕТИЛ[1,2,4]ТРИАЗОЛО[4,3-a]ХИНОКСАЛИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ, СПОСОБЫ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ ИХ, ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ |
| ES2855575T3 (es) | 2012-06-26 | 2021-09-23 | Janssen Pharmaceutica Nv | Combinaciones que comprenden compuestos de 4-metil-[1,2,4]triazolo[4,3-a]quinoxalina como inhibidores de PDE2 e inhibidores de PDE10 para su uso en el tratamiento de trastornos neurológicos o metabólicos |
| KR102171706B1 (ko) | 2012-07-09 | 2020-10-30 | 얀센 파마슈티카 엔.브이. | 포스포디에스테라아제 10 효소의 억제제 |
| BR112015000675B1 (pt) * | 2012-07-13 | 2022-07-12 | UCB Biopharma SRL | Derivados de imidazopiridina como moduladores da atividade de tnf |
| TWI648281B (zh) * | 2013-10-17 | 2019-01-21 | 日商安斯泰來製藥股份有限公司 | 含硫二環式化合物 |
| TW201601632A (zh) | 2013-11-20 | 2016-01-16 | 杜邦股份有限公司 | １－芳基－３－烷基吡唑殺蟲劑 |
| BR112016030930B1 (pt) | 2014-07-02 | 2022-03-15 | Fmc Corporation | Compostos, composições herbicidas, mistura herbicida e método para controle do crescimento de vegetação indesejável |
| US9926316B2 (en) * | 2016-03-03 | 2018-03-27 | The Cleveland Clinic Foundation | Antitumor derivatives for differentiation therapy |
| CN107383005B (zh) * | 2017-09-11 | 2020-03-13 | 华东理工大学 | 6-甲基-2-(4-甲基苯基)咪唑并[1,2-a]吡啶-3-乙酸的制备方法 |
| CN113387946B (zh) * | 2021-05-17 | 2023-08-01 | 衡阳师范学院 | 一种超声辅助多组分合成2-苯基-3-芳胺甲基咪唑并吡啶衍生物的方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU522187A1 (ru) * | 1975-03-12 | 1976-07-25 | Военная Краснознаменная академия химической защиты им.Маршала Советского Союза С.К.Тимошенко | Способ получени 3-ацил-2-алкил (арил)-имидазо (1,2 )пиридинов |
| FR2492382A1 (fr) * | 1980-10-22 | 1982-04-23 | Synthelabo | Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique |
| FR2525601A1 (fr) | 1982-04-21 | 1983-10-28 | Synthelabo | Derives d'imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique |
| FR2568880B1 (fr) * | 1984-08-07 | 1986-12-12 | Synthelabo | Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique |
| DE3666434D1 (de) * | 1985-05-25 | 1989-11-23 | Yoshitomi Pharmaceutical | Oxodiazine compounds |
| FR2647451B1 (fr) * | 1989-05-26 | 1994-08-05 | Sanofi Sa | Derives d'imidazo(1,2-a)pyridine, procede de preparation, compositions pharmaceutiques les contenant |
| DE10040016A1 (de) * | 2000-08-16 | 2002-02-28 | Boehringer Ingelheim Pharma | Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| US6514969B2 (en) * | 2000-08-16 | 2003-02-04 | Boehringer Ingelheim Pharma Kg | β-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions |
| SE0100567D0 (sv) | 2001-02-20 | 2001-02-20 | Astrazeneca Ab | Compounds |
| SE0100568D0 (sv) | 2001-02-20 | 2001-02-20 | Astrazeneca Ab | Compounds |
| CA2450555A1 (en) | 2001-06-25 | 2003-01-03 | Merck & Co., Inc. | (pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds |
| JP2005530788A (ja) | 2002-05-13 | 2005-10-13 | メルク エンド カムパニー インコーポレーテッド | フェニル置換イミダゾピリジン類およびフェニル置換ベンズイミダゾール類 |
-
2004
- 2004-10-28 DE DE602004029272T patent/DE602004029272D1/de not_active Expired - Lifetime
- 2004-10-28 US US10/595,592 patent/US7723324B2/en not_active Expired - Lifetime
- 2004-10-28 US US10/976,331 patent/US7148353B2/en not_active Expired - Lifetime
- 2004-10-28 EP EP04796657A patent/EP1682549B1/en not_active Expired - Lifetime
- 2004-10-28 AT AT04796657T patent/ATE482211T1/de not_active IP Right Cessation
- 2004-10-28 JP JP2006538253A patent/JP2007509960A/ja not_active Withdrawn
- 2004-10-28 CA CA002544213A patent/CA2544213A1/en not_active Abandoned
- 2004-10-28 WO PCT/US2004/035822 patent/WO2005044818A2/en not_active Ceased
- 2004-10-28 AU AU2004287847A patent/AU2004287847A1/en not_active Abandoned
-
2006
- 2006-09-15 US US11/532,402 patent/US7566725B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007509960A5 (cg-RX-API-DMAC7.html) | ||
| CY2025003I2 (el) | Λιποσωματα για τη χορηγηση φαρμακων συνθεσεις για τη θεραπευτικη αγωγη γαστρεντερικων διαταραχων | |
| CY2013022I1 (el) | Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων | |
| MX2011011489A (es) | Derivados de isoxazol-piridina. | |
| CY1121781T1 (el) | Φαρμακοτεχνικες μορφες παρατεταμενης απελευθερωσης της ρασαγιλινης και χρησεις αυτων | |
| MX2009014001A (es) | Derivados de isoxazol-imidazol. | |
| SG135192A1 (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
| MX2011007774A (es) | Derivados de isoxazol-isoxazol e isoxazol-isotiazol. | |
| MX2011011273A (es) | Derivados de isoxazol-pirazol. | |
| MY147442A (en) | Imidazoquinolines as lipid kinase inhibitors | |
| UA100132C2 (en) | Isoxazolo-pyridine derivatives | |
| PA8534801A1 (es) | Derivados de piperazina | |
| MX2009000385A (es) | Acil-anilidas sustituidas y metodos de uso de las mismas. | |
| PA8564001A1 (es) | Aza-arilpiperazinas | |
| JP2003531157A5 (cg-RX-API-DMAC7.html) | ||
| JP2007504174A5 (cg-RX-API-DMAC7.html) | ||
| EA201071006A1 (ru) | Набор, композиция, продукт или лекарственное средство для лечения нарушения познавательной способности | |
| JP2007516193A5 (cg-RX-API-DMAC7.html) | ||
| WO2007084622A3 (en) | Thiophenyl and pyrrolyl azepines as serotonin 5-ht2c receptor ligands and uses thereof | |
| RU2005141060A (ru) | Метаболит кветиапина | |
| TWI372056B (en) | Novel medicament combinations for the treatment of respiratory diseases | |
| MX2011011490A (es) | Derivados de isoxazol-tiazol como agonistas inversos del receptor de acido gamma-aminobutirico a (gaba a), para usarse en el tratamiento de trastornos cognitivos. | |
| JP2005508872A5 (cg-RX-API-DMAC7.html) | ||
| WO2007009720A3 (en) | Prodrugs of pyrazoline compounds, their preparation and use as medicaments | |
| MX2009005544A (es) | Indoles. |